The Drugs of abuse testing market share in 2026 refers to the detection of illicit drugs and prescription medications in biological samples such as urine, blood, saliva, and hair. These tests are widely used in workplaces, hospitals, law enforcement agencies, and rehabilitation centers. Increasing adoption of rapid testing devices, advancements in analytical technologies, and the rising demand for on-site testing solutions are boosting market expansion. Furthermore, the growing emphasis on maintaining workplace safety and productivity is encouraging employers to implement routine drug screening programs.
According to Fortune Business Insights, the global drugs of abuse testing market size was valued at USD 5.97 billion in 2025. The market is projected to grow from USD 6.39 billion in 2026 to USD 11.09 billion by 2034, exhibiting a CAGR of 7.13% during the forecast period. The increasing prevalence of drug abuse across developed and developing nations, combined with rising awareness regarding substance misuse and its health implications, is significantly contributing to the growth of the market. Additionally, stringent government regulations and workplace drug testing policies are further fueling demand for advanced drug testing solutions globally.
The growing incidence of drug and alcohol abuse worldwide is one of the primary drivers of the drugs of abuse testing market. Governments and healthcare organizations are increasingly implementing strict regulations and awareness programs to curb substance misuse. The rising demand for drug screening in workplaces, especially in safety-sensitive industries such as transportation, construction, and healthcare, is further propelling market growth. Additionally, technological advancements such as immunoassay analyzers, chromatography techniques, and portable testing devices are enhancing the accuracy and efficiency of testing procedures.
However, the market faces certain restraints, including the high cost of advanced testing equipment and the possibility of false-positive or false-negative results. Privacy concerns related to drug testing and lack of awareness in some regions may also hinder market growth. Despite these challenges, continuous innovations and increasing investments in research and development are expected to create new opportunities for market players.
The report provides comprehensive insights into the drugs of abuse testing market, including market size, growth trends, and future projections. It covers detailed analysis of key market segments, competitive landscape, and regional dynamics. The report also highlights major industry developments, technological advancements, and regulatory frameworks influencing the market. Furthermore, it offers in-depth information on market drivers, restraints, opportunities, and challenges, enabling stakeholders to make informed business decisions.